According to our knowledge, this study is the first to illustrate the dual oncogenic and tumor-suppressive potential of HTR7 across many cancer types, particularly uncovering previously unreported high expression in malignancies like KIRC, KIRP, PAAD, PCPG, and UCS. Here, HTR7 is linked to neoplasm.